联拓生物计划关闭业务、出售资产、从纳斯达克退市、裁员50%，并派发每股4.80美元的特别现金股息。 LianBio plans to wind down operations, sell assets, delist from Nasdaq, and reduce workforce by 50%, with a special cash dividend of $4.80 per share.
陷入困境的生物科技公司联拓生物宣布计划关闭其业务，包括出售其管道资产、将其美国存托股票从纳斯达克退市，以及裁员 50% 以上。 LianBio, a troubled biotechnology company, announced its plan to wind down its operations, including selling its pipeline assets, delisting its American Depositary Shares from Nasdaq, and reducing its workforce by more than 50%. 该公司董事会宣布派发每股普通股4.80美元的特别现金股息，总计约5.28亿美元。 The company's board declared a special cash dividend of $4.80 per ordinary share, totaling approximately $528 million. 联拓生物预计其大部分关闭活动将于 2024 年底完成。 LianBio anticipates a substantial portion of its wind-down activities to be completed by the end of 2024.